{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,31]],"date-time":"2024-05-31T12:36:07Z","timestamp":1717158967051},"reference-count":25,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2006,7,18]],"date-time":"2006-07-18T00:00:00Z","timestamp":1153180800000},"content-version":"vor","delay-in-days":4200,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intl Journal of Cancer"],"published-print":{"date-parts":[[1995,1,17]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>In order to determine whether serum anti\u2010human T\u2010cell lymphotropic virus type I (HTLV\u2010I) antibody concentration is correlated with cellular viral DNA load, these 2 biological parameters were established in 22 symptomless HTLV\u2010I carriers. The proviral copy (PVC) number was determined through quantificative polymerase chain reaction. Specific antibody titers were determined by Western blot with the end\u2010point dilution method; the quantification of each antibody was performed through ScanGlot by determination of the peak height of each Western\u2010blot band. A positive correlation was observed between the PVC number and the titer of total antibodies. When the association between the peak height of each antibody and the PVC number was studied, a significant positive correlation was observed only with anti\u2010p 19. Further evaluation through follow\u2010up studies of symptomless HTLV\u2010I individuals is needed to clarify the value of anti\u2010HTLV\u2010l antibody titer as a predictor of disease progression. \u00a9 1995 Wiley\u2010Liss, Inc.<\/jats:p>","DOI":"10.1002\/ijc.2910600203","type":"journal-article","created":{"date-parts":[[2010,6,26]],"date-time":"2010-06-26T00:29:49Z","timestamp":1277512189000},"page":"156-159","source":"Crossref","is-referenced-by-count":10,"title":["Correlation between viral dna load and serum anti p19 antibody concentrationtn symptomless human T\u2010lymphotropic virus type\u2010I (HTLV\u2010I)\u2010infected individuals"],"prefix":"10.1002","volume":"60","author":[{"given":"Laurence","family":"Morand\u2010Joubert","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martine","family":"Mariotti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donna","family":"Reed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean\u2010Claude","family":"Petit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean\u2010Jacques","family":"Lefrere","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2006,7,18]]},"reference":[{"key":"e_1_2_1_2_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/166.5.1160"},{"key":"e_1_2_1_3_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/169.4.882"},{"key":"e_1_2_1_4_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/167.4.954"},{"key":"e_1_2_1_5_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199001183220305"},{"key":"e_1_2_1_6_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/166.3.611"},{"key":"e_1_2_1_7_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199002083220607"},{"key":"e_1_2_1_8_1","first-page":"845","article-title":"A new agglutination test for serum antibodies to adult T\u2010cell leukemia virus","volume":"75","author":"Ikeda M.","year":"1984","journal-title":"Jap. J Cancer."},{"key":"e_1_2_1_9_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/161.3.426"},{"key":"e_1_2_1_10_1","first-page":"194","article-title":"Increased HTLV\u2010I proviral DNA in HTLV\u2010I\u2010associated myelopathy: a quantitative polymerase chain reaction study","volume":"29","author":"Kira J. I.","year":"1991","journal-title":"Neurology"},{"key":"e_1_2_1_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/0022-510X(92)90215-7"},{"key":"e_1_2_1_12_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.2910450514"},{"key":"e_1_2_1_13_1","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1182\/blood.V72.4.1117.1117","article-title":"Enzymatic amplification of HTLV\u2010I viral sequences from peripheral blood cells and infected tissues","volume":"72","author":"Kwok S.","year":"1988","journal-title":"Blood"},{"key":"e_1_2_1_14_1","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.1890350404"},{"key":"e_1_2_1_15_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1992.tb06446.x"},{"key":"e_1_2_1_16_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.2910550209"},{"key":"e_1_2_1_17_1","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410210203"},{"key":"e_1_2_1_18_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.77.12.7415"},{"key":"e_1_2_1_19_1","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1128\/jcm.31.2.260-264.1993","article-title":"Evaluation of an immunoblot assay for serological confirmation and differentiation of human T\u2010cell lymphotropic virus types I and II","volume":"31","author":"Roberts B. D.","year":"1993","journal-title":"J. clin. Microbiol"},{"key":"e_1_2_1_20_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.2910370311"},{"key":"e_1_2_1_21_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V78.8.2082.2082"},{"key":"e_1_2_1_22_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.2910540208"},{"key":"e_1_2_1_23_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.2910510415"},{"key":"e_1_2_1_24_1","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410210204"},{"key":"e_1_2_1_25_1","first-page":"943","article-title":"Quantification of HTLV\u2010I proviral copy number in peripheral blood of symptomless carriers from the French West Indies","volume":"5","author":"Wattel E.","year":"1992","journal-title":"J. AIDS"},{"key":"e_1_2_1_26_1","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410260304"}],"container-title":["International Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fijc.2910600203","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ijc.2910600203","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,26]],"date-time":"2023-10-26T00:11:31Z","timestamp":1698279091000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/ijc.2910600203"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1995,1,17]]},"references-count":25,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1995,1,17]]}},"alternative-id":["10.1002\/ijc.2910600203"],"URL":"https:\/\/doi.org\/10.1002\/ijc.2910600203","archive":["Portico"],"relation":{},"ISSN":["0020-7136","1097-0215"],"issn-type":[{"value":"0020-7136","type":"print"},{"value":"1097-0215","type":"electronic"}],"subject":[],"published":{"date-parts":[[1995,1,17]]}}}